Letai: “From this point forward, it really is much more like business as usual at the NCI.”

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

NCI Director Anthony Letai appeared before the National Cancer Advisory Board Committee March 17 to maneuver through thorny topics while reiterating his message of reassurance:

Stability. Stability. Stability. NCI is sturdy and will weather the storms. 

“The mission hasn’t changed at the National Cancer Institute,” Letai said in his remarks to the committee. “The resources have really not changed. The way we choose grants has really not changed. I think there is a certain amount of apprehension—and understandable apprehension, particularly in the extramural community—that this is not the case.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Jacquelyn Cobb
Managing Editor
Table of Contents

YOU MAY BE INTERESTED IN

“I don’t know of a single grant that left my desk that was not approved and funded,” NCI Director Anthony G. Letai said on this episode of The Cancer Letter Podcast. https://open.spotify.com/episode/2PFYGwliBDYEbxBXFd9MtB?si=95DNBAy0QGSKBX31_uETEA This episode is available on Spotify, Apple Podcasts, and Youtube. Letai recapped his first year as NCI director in conversation with Paul Goldberg,...

A year ago, when he was sworn in as director of the National Cancer Institute, Anthony G. Letai set a goal: Reassure cancer researchers that the institute will keep a steady course aimed at finding treatments for cancer.
Jacquelyn Cobb
Managing Editor

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login